BR112014017483A2 - derivados de espiroindolina e composições farmacêuticas dos mesmos - Google Patents
derivados de espiroindolina e composições farmacêuticas dos mesmosInfo
- Publication number
- BR112014017483A2 BR112014017483A2 BR112014017483A BR112014017483A BR112014017483A2 BR 112014017483 A2 BR112014017483 A2 BR 112014017483A2 BR 112014017483 A BR112014017483 A BR 112014017483A BR 112014017483 A BR112014017483 A BR 112014017483A BR 112014017483 A2 BR112014017483 A2 BR 112014017483A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- derivatives
- diseases
- prophylaxis
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
resumo patente de invenção: "derivados de espiroindolina e composições farmacêuticas dos mesmos". derivados de epiroindolina, processo para sua preparação e composições farmacêuticas dos mesmos, seu uso para o tratamento e/ou profilaxia de doenças, e uso do mesmo para a fabricação de medicamentos para o tratamento e/ou profilaxia de doenças, especialmente doenças relacionadas ao hormônio sexual igualmente em homem e mulher, particularmente aquelas selecionadas a partir do grupo de endometriose, fibroides uterinos, doença do ovário policístico, hirsutismo, puberdade precoce, neoplasia dependente de esteroide gonadal, tais como cânceres de próstata, mama e ovário, adenomas pituitários gonadotrópicos, apneia do sono, síndrome do intestino irritável, síndrome pré-menstrual, hipertrofia prostática benigna, contracepção e infertilidade (por exemplo, terapia reprodutiva assistida, tal como fertilização in vitro). o presente pedido refere-se, em particular, aos derivados de espiroindolina como antagonistas do receptor do hormônio liberador de gonadotropina (gnrh).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12151291 | 2012-01-16 | ||
PCT/EP2013/050676 WO2013107743A1 (en) | 2012-01-16 | 2013-01-15 | Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014017483A2 true BR112014017483A2 (pt) | 2017-06-13 |
BR112014017483A8 BR112014017483A8 (pt) | 2017-07-04 |
Family
ID=47559493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014017483A BR112014017483A8 (pt) | 2012-01-16 | 2013-01-15 | derivados de espiroindolina e composições farmacêuticas dos mesmos |
Country Status (25)
Country | Link |
---|---|
US (1) | US20140357655A1 (pt) |
EP (1) | EP2804867A1 (pt) |
JP (1) | JP2015503607A (pt) |
KR (1) | KR20140112075A (pt) |
CN (1) | CN104169287A (pt) |
AP (1) | AP2014007738A0 (pt) |
AU (1) | AU2013211091A1 (pt) |
BR (1) | BR112014017483A8 (pt) |
CA (1) | CA2860986A1 (pt) |
CL (1) | CL2014001871A1 (pt) |
CO (1) | CO7010832A2 (pt) |
CR (1) | CR20140343A (pt) |
CU (1) | CU20140088A7 (pt) |
DO (1) | DOP2014000167A (pt) |
EA (1) | EA201491344A1 (pt) |
GT (1) | GT201400153A (pt) |
HK (1) | HK1199878A1 (pt) |
IL (1) | IL233485A0 (pt) |
MA (1) | MA35867B1 (pt) |
MX (1) | MX2014008630A (pt) |
PE (1) | PE20141699A1 (pt) |
PH (1) | PH12014501616A1 (pt) |
SG (1) | SG11201403749VA (pt) |
TN (1) | TN2014000306A1 (pt) |
WO (1) | WO2013107743A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR095785A1 (es) * | 2013-04-09 | 2015-11-11 | Bayer Pharma AG | Derivados de espiroindolina y composiciones farmacéutica de los mismos |
WO2015007606A1 (en) * | 2013-07-15 | 2015-01-22 | Bayer Pharma Aktiengesellschaft | Spiroindoline derivatives and pharmaceutical compositions thereof |
WO2015082374A1 (en) * | 2013-12-05 | 2015-06-11 | Bayer Pharma Aktiengesellschaft | Spiroindoline-thiopyran-imine-oxide derivatives as gonadotropin-releasing hormone receptor antagonists and pharmaceutical compositions thereof |
EP2881391A1 (en) | 2013-12-05 | 2015-06-10 | Bayer Pharma Aktiengesellschaft | Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof |
WO2015091315A1 (en) * | 2013-12-19 | 2015-06-25 | Bayer Pharma Aktiengesellschaft | Spiro[indolin-3,4'-piperidine] derivatives as gnrh receptor antagonists |
EP3339846B1 (en) * | 2016-12-22 | 2020-12-09 | Malvern Panalytical B.V. | Method of measuring properties of a thin film stack |
CN110996956A (zh) | 2017-06-05 | 2020-04-10 | 奥布赛瓦股份公司 | 用于治疗子宫内膜异位症的促性腺激素释放激素拮抗剂给药方案 |
CN107840851A (zh) * | 2017-12-21 | 2018-03-27 | 扬州大学 | 吲哚螺吡咯嗪化合物及其合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849780A (en) * | 1992-01-30 | 1998-12-15 | Sanofi | 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
TW200522944A (en) * | 2003-12-23 | 2005-07-16 | Lilly Co Eli | CB1 modulator compounds |
-
2013
- 2013-01-15 CN CN201380014647.3A patent/CN104169287A/zh active Pending
- 2013-01-15 EP EP13700304.2A patent/EP2804867A1/en not_active Withdrawn
- 2013-01-15 KR KR1020147022494A patent/KR20140112075A/ko not_active Application Discontinuation
- 2013-01-15 AU AU2013211091A patent/AU2013211091A1/en not_active Abandoned
- 2013-01-15 BR BR112014017483A patent/BR112014017483A8/pt not_active Application Discontinuation
- 2013-01-15 EA EA201491344A patent/EA201491344A1/ru unknown
- 2013-01-15 WO PCT/EP2013/050676 patent/WO2013107743A1/en active Application Filing
- 2013-01-15 AP AP2014007738A patent/AP2014007738A0/xx unknown
- 2013-01-15 US US14/371,312 patent/US20140357655A1/en not_active Abandoned
- 2013-01-15 MX MX2014008630A patent/MX2014008630A/es unknown
- 2013-01-15 PE PE2014001114A patent/PE20141699A1/es not_active Application Discontinuation
- 2013-01-15 JP JP2014551648A patent/JP2015503607A/ja active Pending
- 2013-01-15 CA CA2860986A patent/CA2860986A1/en not_active Abandoned
- 2013-01-15 SG SG11201403749VA patent/SG11201403749VA/en unknown
-
2014
- 2014-07-02 IL IL233485A patent/IL233485A0/en unknown
- 2014-07-11 PH PH12014501616A patent/PH12014501616A1/en unknown
- 2014-07-15 MA MA37214A patent/MA35867B1/fr unknown
- 2014-07-15 TN TNP2014000306A patent/TN2014000306A1/fr unknown
- 2014-07-15 CL CL2014001871A patent/CL2014001871A1/es unknown
- 2014-07-16 DO DO2014000167A patent/DOP2014000167A/es unknown
- 2014-07-16 GT GT201400153A patent/GT201400153A/es unknown
- 2014-07-16 CO CO14154059A patent/CO7010832A2/es not_active Application Discontinuation
- 2014-07-16 CU CU2014000088A patent/CU20140088A7/es unknown
- 2014-07-16 CR CR20140343A patent/CR20140343A/es unknown
-
2015
- 2015-01-13 HK HK15100323.1A patent/HK1199878A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL233485A0 (en) | 2014-08-31 |
CN104169287A (zh) | 2014-11-26 |
TN2014000306A1 (en) | 2015-12-21 |
AU2013211091A1 (en) | 2014-08-07 |
SG11201403749VA (en) | 2014-07-30 |
CR20140343A (es) | 2014-09-08 |
EA201491344A1 (ru) | 2015-04-30 |
JP2015503607A (ja) | 2015-02-02 |
US20140357655A1 (en) | 2014-12-04 |
KR20140112075A (ko) | 2014-09-22 |
AP2014007738A0 (en) | 2014-07-31 |
PH12014501616A1 (en) | 2014-10-13 |
BR112014017483A8 (pt) | 2017-07-04 |
EP2804867A1 (en) | 2014-11-26 |
WO2013107743A1 (en) | 2013-07-25 |
HK1199878A1 (en) | 2015-07-24 |
CO7010832A2 (es) | 2014-07-31 |
CL2014001871A1 (es) | 2014-11-03 |
CA2860986A1 (en) | 2013-07-25 |
PE20141699A1 (es) | 2014-11-29 |
DOP2014000167A (es) | 2014-08-31 |
MX2014008630A (es) | 2014-08-29 |
CU20140088A7 (es) | 2014-12-26 |
MA35867B1 (fr) | 2014-12-01 |
GT201400153A (es) | 2015-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014017483A8 (pt) | derivados de espiroindolina e composições farmacêuticas dos mesmos | |
JO3732B1 (ar) | مشتقات 17-هيدروكسي-17بنتافلوروإيثيل-إسترا-4،9(10)-دين-11-أريل، طريقة لإنتاجها واستخدامها في معالجة الأمراض | |
IN2012DN05082A (pt) | ||
WO2009134718A8 (en) | Progesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc | |
WO2012127501A3 (en) | Composition for improving endometrial thickness during ovarian stimulation | |
JP2013513559A5 (pt) | ||
BR112014021331A8 (pt) | Antagonistas do receptor do hormônio liberador de gonadotropina, composição farmacêutica compreendendo os mesmos e uso desses | |
WO2011098437A3 (de) | Progesteronrezeptorantagonisten | |
TN2012000618A1 (en) | 6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments | |
WO2011009534A3 (de) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten | |
BR112015025700A2 (pt) | derivados de espiroindolina e suas composições farmacêuticas | |
BR9911564A (pt) | Composto, processo para produzir um composto, composição farmacêutica, processo para antagonizar o hormÈnio de liberação de gonadotropina em um mamìfero, e, uso de um composto | |
AR096905A1 (es) | Derivados de espiroindolina y composiciones farmacéuticas de los mismos | |
UA116471C2 (uk) | Дозована форма антагоніста рецептора прогестерону | |
NZ612295A (en) | Novel 19-nor-steroids and their use for treating progesterone-dependent conditions | |
Qinghua et al. | Evaluation of the clinical value of simultaneous hysterectomy and bilateral salpingectomy in perimenopausal women | |
TN2011000022A1 (en) | Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a - ring |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |